The overall process for developing and manufacturing vaccines and cell and gene therapies (CGTs) is challenging and resource intensive because it involves complex and variable raw materials, demanding ...
Discover expert strategies for selecting optimal labels for single particle tracking in super-resolution microscopy ...
A new, label-free method for identifying aged human cells has been developed. Researchers from Tokyo Metropolitan University (Japan) have created a new way of telling ‘aged’ human cells apart from ...
Zacks Investment Research on MSN
Will Breyanzi's label expansion boost BMY's CAR T cell therapy sales?
Bristol Myers Squibb BMY recently obtained FDA approval for the label expansion of Breyanzi (lisocabtagene maraleucel) for ...
A team of researchers at IOCB Prague headed by Dr. Tomáš Slanina has developed a new method for labeling molecules with fluorescent dyes that surpasses existing approaches in both precision and ...
Gladstone scientists unveiled a powerful computation tool, called CellWalker2, that integrates different forms of biological data to reveal how cell types are related across tissues, experiments, and ...
Artificial intelligence has exploded in popularity in recent years, and many proponents are excited about its potential uses in medicine: for example, processing samples quickly or identifying markers ...
Zacks Investment Research on MSN
BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi
Bristol Myers Squibb BMY obtained the European Commission’s (“EC”) approval for a label expansion of Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T ...
Please provide your email address to receive an email when new articles are posted on . The FDA has requested manufacturers of commercially available chimeric antigen receptor T-cell therapies now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results